Meijerink MR, Puijk RS, van Tilborg A, et al. Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2018;41:1189–204.
PubMed
PubMed Central
Article
Google Scholar
Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273:241–60.
PubMed
Article
Google Scholar
Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11–7.
PubMed
Article
Google Scholar
Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontiers meeting 2013. Eur Radiol. 2015;25:3438–54.
PubMed
PubMed Central
Article
Google Scholar
Bala MM, Riemsma RP, Wolff R, et al. Microwave coagulation for liver metastases. Cochrane Database Syst Rev. 2013;1:010163.
Google Scholar
Puijk RS, Ruarus AH, Scheffer HJ, et al. Percutaneous liver tumour ablation: image guidance, endpoint assessment, and quality control. Can Assoc Radiol J. 2018;69:51–62.
PubMed
Article
Google Scholar
de Baere T, Tselikas L, Yevich S, et al. The role of image-guided therapy in the management of colorectal cancer metastatic disease. Eur J Cancer. 2017;75:231–42.
PubMed
Article
Google Scholar
Salhab M, Canelo R. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis. J Cancer Res Ther. 2011;7:463–75.
CAS
PubMed
Article
Google Scholar
Nielsen K, van Tilborg AA, Meijerink MR, et al. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg. 2013;37:1340–7.
PubMed
Article
Google Scholar
Vasiniotis Kamarinos N, Kaye EA, Sofocleous CT. Image-guided thermal ablation for colorectal liver metastases. Tech Vasc Interv Radiol. 2020;23: 100672.
CAS
PubMed
Article
Google Scholar
Giglio MC, Logghe B, Garofalo E, et al. Laparoscopic versus open thermal ablation of colorectal liver metastases: a propensity score-based analysis of local control of the ablated tumors. Ann Surg Oncol. 2020;27:2730.
Article
Google Scholar
Santambrogio R, Bianchi P, Pasta A, et al. Ultrasound-guided interventional procedures of the liver during laparoscopy: technical considerations. Surg Endosc. 2002;16:349–54.
CAS
PubMed
Article
Google Scholar
Takahashi H, Berber E. Role of thermal ablation in the management of colorectal liver metastasis. Hepatobiliary Surg Nutr. 2020;9:49–58.
PubMed
PubMed Central
Article
Google Scholar
Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes–a 10-year experience at a single center. Radiology. 2016;278:601–11.
PubMed
Article
Google Scholar
Elias D, De Baere T, Smayra T, et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg. 2002;89:752–6.
CAS
PubMed
Article
Google Scholar
Sofocleous CT, Petre EN, Gonen M, et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol. 2011;22:755–61.
PubMed
PubMed Central
Article
Google Scholar
Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach.” Cancer. 2003;97:3027–35.
PubMed
Article
Google Scholar
Nieuwenhuizen S, Puijk RS, van den Bemd B, et al. Resectability and ablatability criteria for the treatment of liver only colorectal metastases: multidisciplinary consensus document from the COLLISION Trial Group. Cancers (Basel). 2020;12:1779.
CAS
Article
Google Scholar
Solbiati L, Ahmed M, Cova L, et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265:958–68.
PubMed
Article
Google Scholar
Shi Y, Wang Z, Chi J, et al. Long-term results of percutaneous microwave ablation for colorectal liver metastases. HPB (Oxford). 2021;23:37–45.
Article
Google Scholar
Puijk RS, Des Plantes VZ, Nieuwenhuizen S, et al. Propofol compared to midazolam sedation and to general anesthesia for percutaneous microwave ablation in patients with hepatic malignancies: a single-center comparative analysis of three historical cohorts. Cardiovasc Intervent Radiol. 2019;42:1579–2068.
Article
Google Scholar
Puijk RS, Nieuwenhuizen S, van den Bemd BAT, et al. Transcatheter CT hepatic arteriography compared with conventional CT fluoroscopy guidance in percutaneous thermal ablation to treat colorectal liver metastases: a single-center comparative analysis of 2 historical cohorts. J Vasc Interv Radiol. 2020;31:1772–83.
PubMed
Article
Google Scholar
Solbiati M, Muglia R, Goldberg SN, et al. A novel software platform for volumetric assessment of ablation completeness. Int J Hyperthermia. 2019;36:337–43.
PubMed
Article
Google Scholar
Kaye EA, Cornelis FH, Petre EN, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29:2698–705.
PubMed
Article
Google Scholar
Laimer G, Schullian P, Bale R. Stereotactic thermal ablation of liver tumors: 3D planning, multiple needle approach, and intraprocedural image fusion are the key to success-a narrative review. Biology (Basel). 2021;10:644.
Google Scholar
Laimer G, Jaschke N, Schullian P, et al. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases. Eur Radiol. 2021;31:6489–99.
PubMed
PubMed Central
Article
Google Scholar
Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301:533.
PubMed
Article
Google Scholar
Vietti Violi N, Duran R, Demartines N, et al. Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation. Int J Hyperthermia. 2018;34:1020–8.
PubMed
Article
Google Scholar
Yu J, Liang P, Yu XL, et al. Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours. Eur Radiol. 2015;25:1119–26.
PubMed
Article
Google Scholar
Wong J, Lee KF, Yu SC, et al. Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results. HPB (Oxford). 2013;15:595–601.
Article
Google Scholar
Shady W, Petre EN, Do KG, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29:268–75.
PubMed
Article
Google Scholar
Elias D, Baton O, Sideris L, et al. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol. 2004;11:500–5.
PubMed
Article
Google Scholar
Hamada A, Yamakado K, Nakatsuka A, et al. Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates. Jpn J Radiol. 2012;30:567–74.
PubMed
Article
Google Scholar
Tsitskari M, Filippiadis D, Zavridis P, et al. Efficacy and safety of percutaneous computed tomography-guided microwave ablation for colorectal cancer, oligometastatic liver-only disease: a single center’s experience. Ann Gastroenterol. 2021;34:61–7.
PubMed
Google Scholar
Faitot F, Faron M, Adam R, et al. Two-stage hepatectomy versus 1-stage resection combined with radiofrequency for bilobar colorectal metastases: a case-matched analysis of surgical and oncological outcomes. Ann Surg. 2014;260:822–7 (discussion 827-828).
PubMed
Article
Google Scholar
Tinguely P, Dal G, Bottai M, et al. Microwave ablation versus resection for colorectal cancer liver metastases - a propensity score analysis from a population-based nationwide registry. Eur J Surg Oncol. 2020;46:476–85.
PubMed
Article
Google Scholar
Hof J, Wertenbroek MW, Peeters PM, et al. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases. Br J Surg. 2016;103:1055–62.
CAS
PubMed
Article
Google Scholar
Imai K, Allard MA, Castro Benitez C, et al. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases. Br J Surg. 2017;104:570–9.
CAS
PubMed
Article
Google Scholar
Karanicolas PJ, Jarnagin WR, Gonen M, et al. Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg. 2013;148:597–601.
PubMed
PubMed Central
Article
Google Scholar
Snyder RA, Hao S, Irish W, et al. Thirty-day morbidity after simultaneous resection of colorectal cancer and colorectal liver metastasis: American College of Surgeons NSQIP Analysis. J Am Coll Surg. 2020;230:617–27.
PubMed
Article
Google Scholar
Comprehensive Cancer Organisation the Netherlands (I.K.N.L.). National evidence-based guideline. Colorectaalcarcinoom. https://richtlijnendatabase.nl/richtlijn/colorectaal_carcinoom_crc/startpagina_-_crc.html, Nov 2019. Accessed November 10, 2021
Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0 and 5.0 [Internet]. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm, Accessed November 10, 2021
IBM Corp. Released 2013. IBM® SPSS® Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp.
(2019) RCT: R: A language and environment for statistical computing. R for Windows version 4.0.3. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.
STROBE Statement - Checklist of items that should be included in reports of cohort studies. Version 4. Oct/Nov 2007. ISPM - University of Bern 2009. www.strobe-statement.org. Accessed 10 Nov 2021.
Eltawil KM, Boame N, Mimeault R, et al. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases. J Surg Oncol. 2014;110:734–8.
PubMed
Article
Google Scholar
Calandri M, Yamashita S, Gazzera C, et al. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival. Eur Radiol. 2018;28:2727–34.
PubMed
Article
Google Scholar
Schiesser M, Chen JW, Maddern GJ, et al. Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg. 2008;12:1054–60.
CAS
PubMed
Article
Google Scholar
Are C, Gonen M, Zazzali K, et al. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 2007;246:295–300.
PubMed
PubMed Central
Article
Google Scholar
Hamady ZZ, Lodge JP, Welsh FK, et al. One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg. 2014;259:543–8.
PubMed
Article
Google Scholar
de Haas RJ, Wicherts DA, Flores E, et al. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248:626–37.
PubMed
Article
Google Scholar
Sadot E, Koerkamp BG, Leal JN, et al. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? Ann Surg. 2015;262:476–85.
PubMed
Article
Google Scholar
Davidson B, Gurusamy K, Corrigan N, et al. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT. Health Technol Assess. 2020;24(21):1–38.
PubMed
PubMed Central
Article
Google Scholar
Puijk RS, Ruarus AH, Vroomen L, et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial. BMC Cancer. 2018;18:821.
PubMed
PubMed Central
Article
Google Scholar
Meijerink MR, Puijk RS, van den Tol MP, Dijkstra M, et al. COLLISION trial interim results: surgery vs. MWA. https://library.cirse.org/speakers/53812. Presented at the CIRSE 2021 Summit, Virtual, Sept 25–29, 2021
Nieuwenhuizen S, Dijkstra M, Puijk RS, et al. Thermal ablation versus stereotactic ablative body radiotherapy to treat unresectable colorectal liver metastases: a comparative analysis from the prospective Amsterdam CORE Registry. Cancers. 2021;13:1.
Article
CAS
Google Scholar
Laimer G, Schullian P, Jaschke N, et al. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol. 2020;30:2463.
PubMed
PubMed Central
Article
Google Scholar
Wright AS, Lee FT Jr, Mahvi DM. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol. 2003;10:275–83.
PubMed
Article
Google Scholar
Puijk RS, des Plantes VZ, Nieuwenhuizen S, et al. Propofol compared to midazolam sedation and to general anesthesia for percutaneous microwave ablation in patients with hepatic malignancies: a single-center comparative analysis of three historical cohorts. Cardiovasc Intervent Radiol. 2019;42:1597–608.
PubMed
PubMed Central
Article
Google Scholar
Alonzo M, Bos A, Bennett S, et al. The emprint ablation system with thermosphere technology: one of the newer next-generation microwave ablation technologies. Semin Intervent Radiol. 2015;32:335–8.
PubMed
PubMed Central
Article
Google Scholar
Radosevic A, Quesada R, Serlavos C, et al. Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial. Sci Rep. 2022;12:316.
CAS
PubMed
PubMed Central
Article
Google Scholar
Odisio BC, Yamashita S, Huang SY, et al. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. Br J Surg. 2017;104:760–8.
CAS
PubMed
PubMed Central
Article
Google Scholar
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14:1208–15.
CAS
PubMed
Article
Google Scholar
Kanemitsu Y, Kato T, Shimizu Y, et al. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603. Jpn J Clin Oncol. 2009;39:406–9.
PubMed
Article
Google Scholar